Uterine Fibroids

• CLINICAL_TRIALS withdrawal · 2026-02-04
  Clinical Trial Update: Holistic Medicine Treatment of Uterine Fibroids-Adults [NA]

  The clinical trial NCT07219381 investigating holistic medicine treatment for uterine fibroids in adults has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2025-09-29
  Clinical Trial Update: Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) [Phase 4]

  Phase 4 SOUL trial evaluating post-surgical Myfembree versus standard of care has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2025-09-17
  Clinical Trial Update: A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

  AbbVie-sponsored trial evaluating hair changes in adults taking Oriahnn for heavy menstrual bleeding due to uterine fibroids has been withdr…

• EMA withdrawal · 2025-08-20
  EMA Withdrawn: Esmya (ulipristal acetate) — Gedeon Richter Ltd

  The European Medicines Agency has withdrawn the marketing authorisation for Esmya (ulipristal acetate) by Gedeon Richter Ltd for the treatme…

• CLINICAL_TRIALS withdrawal · 2024-05-30
  Clinical Trial Update: Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids

  A clinical trial evaluating tibolone add-back in patients with endometriosis and uterine fibroids has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2023-10-24
  Clinical Trial Update: Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future [Phase 4]

  A Phase 4 safety trial of MR-guided focused ultrasound for uterine fibroids in women desiring future pregnancy has been withdrawn.

• EMA withdrawal · 2020-09-04
  PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids

  The European Medicines Agency's PRAC recommended revoking the marketing authorisation of ulipristal acetate for treating uterine fibroids du…

• CLINICAL_TRIALS withdrawal · 2020-01-18
  Clinical Trial Update: Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids [Phase 3]

  Phase 3 trial assessing vilaprisan for uterine fibroids has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2018-06-15
  Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids [NA]

  A clinical trial evaluating MR-guided focused ultrasound (MRgFUS) versus myomectomy for uterine fibroids has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2018-05-22
  Clinical Trial Update: Uterine Artery Embolization and Pelvic Floor Symptoms

  A clinical trial evaluating uterine artery embolization for uterine fibroids and related pelvic floor symptoms has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2017-08-10
  Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet [Phase 1]

  Phase 1 study comparing pharmacokinetics and safety/tolerability of BR-UPS (Ulipristal Acetate) 5 mg tablet versus Inisia (Ulipristal Acetat…

• CLINICAL_TRIALS withdrawal · 2017-01-25
  Clinical Trial Update: a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. [NA]

  A clinical trial evaluating adhesion risk after laparoscopic myomectomy in fertility patients has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-04-15
  Clinical Trial Update: Endometrial and Myometrial Changes, With and Without Fibroids

  A clinical trial evaluating endometrial and myometrial changes in women with and without uterine fibroids has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2014-06-27
  Clinical Trial Update: Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms [Phase 3]

  Phase 3 trial evaluating 25 mg and 50 mg doses of Proellex for recurrence of uterine fibroid symptoms has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2013-11-25
  Clinical Trial Update: Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study [NA]

  A clinical trial evaluating radiofrequency ablation for uterine fibroids to reduce menstrual bleeding has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2013-02-07
  Clinical Trial Update: Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma [Phase 3]

  Phase 3 trial evaluating ulipristal acetate for anemia associated with uterine fibroids has been withdrawn with no results reported.

• CLINICAL_TRIALS withdrawal · 2012-07-13
  Clinical Trial Update: Aromatase Inhibitors for Treatment of Uterine Leiomyomas [Phase 1]

  A Phase 1 clinical trial of aromatase inhibitors for treating uterine fibroids has been withdrawn.